In the efficacy estimand, tirzepatide compared with placebo demonstrated a significant increase in change in 6-minute walk distance (38.2 vs 7.9 meters), a greater change in body weight (-15.7 vs -2.2 ...

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reductio ...

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...

Tirzepatide by Eli Lilly reduces heart failure risk in adults with HFpEF and obesity, showing promising results for both ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

New medication that can cut body weight by 23% could radically reduce the number of people who are obese. Tirzepatide is ...

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...

CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...

When it comes to weight loss journeys, we often focus on before-and-after photos and diet tips. But what happens when your ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Gaffigan admitted to having trepidation to use the medication, a brand name for tirzepatide, after tipping the scales at 270 ...